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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S486phases, we were able to encapsulate single chondrocytes in stable
monodisperse PEGDAmicrogels with a controlled diameter between 30
and 50 mm in a cell-friendly manner.
Conclusions: We have developed a microﬂuidic platform and opti-
mized the production process for the encapsulation of single chon-
drocytes in chondron-sized microgels at a typical rate of 20,000 cells
per minute. Future work will focus on the functionalization of the
microenvironment within the biomaterial by means of incorporation of
growth factors and extracellular matrix molecules to create biomimetic
and chondrogenic artiﬁcial chondrons.
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OXYGEN IS A CRITICAL PARAMETER FOR CHONDROGENIC
DIFFERENTIATION OF HUMAN UMBILICAL CORD BLOOD
MESENCHYMAL STEM CELL IN 3D-CULTURES
T. Gomez-Leduc y, M. Hervieu y, M. Desance y, C. Drougard y,
D. Ollitrault y, L. Poulain z, F. Legendre y, P. Galera y, M. Demoor y. y Lab. of
Cellular Microenvironnement and Pathologies (MILPAT), Caen, France;
zBIOTICLA-UCBN, Caen, France
Purpose: The autologous chondrocyte implantation technique presents
many limitations for cartilage disease treatment. The surgical process is
traumatic and few chondrocytes are harvested. Mesenchymal stem cells
(MSCs) represent a promising clinical tool for cartilage regeneration and
osteoarthritis (OA) therapy. Although adult bonemarrow has been up to
now the main source of MSCs, their harvest is also a highly invasive
procedure and their number, differentiation potential, and maximal life
span decline with increasing age. The umbilical cord blood mesen-
chymal stem cells (UCB-MSCs) are a promising alternative source, due
to abundant resources, painless and non-invasive collection process and
are rapidly expandable in in vitro cultures. The aim of our study was to
determine the chondrogenic differentiation potential of human UCB-
MSCs for cartilage tissue engineering.
Methods: The UCB were collected after full term and normal delivery
pregnancy. Cell ampliﬁcation, karyotype, osteoblasts and adipocytes
differentiation of UCB-MSCs were realized in normoxia. XTT cell assay
was performed after 7 days under normoxic (21% O2) or hypoxic (< 5%
O2) culture conditions. Cumulative population doublings and several
surface markers of MSCs were analyzed up to the seventh passage. The
chondrogenic differentiationwas induced using an innovative approach
combining 3D-culture in type I collagen sponges and chondrogenic
factors (BMP-2  TGF-ß1) in normoxia or in hypoxia. Chondrogenic
differentiation was then evaluated by real-time RT-PCR, Western-blot-
ting and immunoﬂuorescence microscopy after 7, 14 and 21 days of cell
differentiation. The nature of the hyaline neo-tissue obtained after 14
days of in vitro differentiation was veriﬁed by subcutaneous implan-
tation in the nude mice. The neo-tissue was collected after 35 days and
histological examination was performed using hematoxylin-eosin-
safran and alizarin red, as well as type I- and II-collagen immunohis-
tochemistry analyses.
Results: 127 UCB samples were obtained with a mean volume of 41.15
 22.95 mL. Taking into account of only those with a minimal volume
of 55 mL, the success efﬁciency was enhanced from 30% to 57%. Flow
cytometry results showed that the isolated cells expressed CD29,
CD44, CD73, CD90, CD105, CD166 and did not express CD14, CD34,
CD45, CD64 and HLA-DR. There was no signiﬁcant variation of those
markers all along cell ampliﬁcation. Otherwise, CD146 expression was
shown to be donor- and passage-dependent. Interestingly, the growth
of hypoxic UCB-MSC in monolayers induced the formation of cell
spheres and a decrease in cell metabolism. Cells were shown to dif-
ferentiate mainly in osteoblasts but not in adipocytes. The addition of
BMP-2 and TGF-ß1 allowed to enhance chondrogenesis both in nor-
moxia and hypoxia. Surprisingly, differentiation occurred earlier and at
a higher level in normoxic compared to hypoxic conditions. These
observations were conﬁrmed by the analysis of 12 chondrogenic
related genes and type II collagen protein. An increase in expression of
speciﬁc cartilage markers (SOX9, COL2A1, COLIIB, ACAN et SNORC) and a
slight MMP13 expression were observed during the culture. Otherwise,
hypoxia presented beneﬁcial effects by decreasing type X collagen. All
the neo-tissue generated in vitro and injected in mice demonstrated
that cells treated with BMP-2 and TGF-ß1 in normoxia showed a better
phenotype maintenance with a more organized and abundant type II
collagen matrix. Alizarin red staining was negative for all the donors.
Conclusions:Our experiments demonstrated that UCB-MSCs could be a
reliable cell source for cartilage tissue engineering. In this sense, wesuggest that UBC-MSCs cultured in in vitro 3D-culture can begin
chondrogenesis in normoxic conditions to obtain a more efﬁcient
chondrogenic differentiation, before placing them in hypoxic conditions
to stabilize the phenotype before in vivo implantation.
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BLOCK OF ANGIOGENESIS ENHANCES IN VIVO CHONDROGENESIS OF
NASAL CHONDROCYTES-BASED CONSTRUCTS
C.M. Medeiros da Cunha y, V. Perugini z, P. Bernegger y, M. Centola y,
M. Santin z, A. Banﬁ y, I. Martin y, A. Marsano y. yUniv. Hosp. Basel, Basel,
Switzerland; zUniv. of Brighton, Brighton, United Kingdom
Background/Aim: Vascular Endothelial Growth Factor (VEGF) is
involved in regulating cartilage growth and endochondral ossiﬁcation
during growth plate development, but also in degenerative processes
e.g. in osteoarthritis or following mechanical overloading. On the other
hand, VEGF expression is suppressed during hyaline cartilage formation
and maintenance, and blocking of angiogenesis results in improved
cartilage repair inmurinemodels. We sought to investigatewhether the
sole blockade of the endogenous VEGF pathway could improve in vivo
chondrogenesis in engineered tissues based on nasal chondrocytes
(NC). Blockage of VEGF was achieved by transducing BMSC to express
soluble VEGF receptor-2 (sFlk-1).
Methods: Human NCs were retrovirus-transduced to overexpress the
soluble form of human VEGF receptor 2 (sFlk-1). Cell-based constructs
were generated with either sFlk-1-expressing or control cells loaded on
collagen-based scaffolds. To investigate their in vivo chondrogenenic
potential, the constructs were implanted in an ectopic mouse model.
Vessel formation, VEGF activity, cartilage biochemistry and histology
were performed to evaluate how the intrinsic chondrogenic capacity of
NCs could beneﬁt from blocking VEGF pathway.
Results: The released sFlk-1 blocked blood vessel ingrowth within the
implant. Blood vessel ingrowth was signiﬁcantly reduced in the engi-
neered tissues developed by sFlk-1-expressing cells compared to con-
trol cells. sFlk-1 did not appear to regulate the in vitro chondrogenic
differentiation of NCs. However, frank chondrogenesis in vivo could
only be observed in the constructs generated by NCs expressing sFlk-1.
Cartilaginous extracellular matrix was stable up to 8 weeks in vivo.
Conclusion: VEGF blockage was sufﬁcient to induce in vivo chondro-
genesis of NC in the absence of other exogenous morphogens. The long-
term stability of the generated cartilage requires further investigations.
The overexpression of sFlk-1 and the associated reduction in blood
vessel ingrowth has profound effects on in vivo chondrogenesis by NCs,
even in the absence of chondroinductive signals at the implant site. The
absence of such effect in the in vitro model suggests a predominant
paracrine mechanism, related to the control of angiogenesis by host
cells.
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ARE UMBILICAL CORD MESENCHYMAL STEM CELLS ADVANTAGEOUS
OVER BONE MARROW MESENCHYMAL STEM CELLS FOR CELL
THERAPY IN ORTHOPAEDICS?
C. Mennan y, S. Owen y, E. Mayrogonatou z, D. Kletsas z, R. Oldershaw x,
J. Richardson y, S. Roberts y. y ISTM & Keele Univ., Oswestry, United
Kingdom; zNatl. Ctr. for Scientiﬁc Res., Athens, Greece; xNewcastle Univ.,
Newcastle upon-tyne, United Kingdom
Purpose:Mesenchymal Stem cells (MSC) from umbilical cords (UC) are
of increasing interest for cell therapy in degenerative musculoskeletal
disorders as they present little ethical consideration and are reported to
contain immune privileged cells, which may be suitable for allogeneic
based therapies. The use of MSCs as allogeneic cells in vivo would only
be possible if they retained their immune privileged properties in an
inﬂammatory environment. We have previously shown that cells
obtained from UC are multipotent and have the recommended MSC cell
surface marker proﬁle according to the International Society for Cellular
Therapy. The focus of this study was to characterise the immune
properties of MSCs isolated from UC, particularly Wharton’s jelly (WJ)
and cells fromwhole cord (MC) as we have previously shown that cells
from these cord regions have the best multipotency. MC and WJ were
compared to Bone Marrow MSCs (BMSCs) in order to utilise the most
promising population of stem cells and to analyse the immune prop-
erties of these cells before and after stimulation with the pro-inﬂam-
matory cytokine, interferon-g (IFN-g).
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S487Methods: Umbilical cords were dissected to obtain WJ and MC was
obtained from aw2 cm section of whole cord, which was minced into
small (w2mm2) pieces and digested in collagenase I for 1 h at 37C.
Resulting cells were cultured in DMEM-F12, 10 % FCS and Penicillin/
streptomycin. Flow cytometry, immunocytochemistry and Western
blotting was used to characterise cell markers indicative of pluripotency
(SOX2, Nanog, REX-1, OCT3/4, SSEA-3, 4, TRA-1-60, TRA-1-81 and
alkaline phosphatase) and immunogenicity (using co-stimulatory
markers, CD40, 80, 86, in addition to HLA-G, Indoleamine 2 3-dioxy-
genase and HLA-DR) before and after stimulationwith IFN-g (500 ng/ml
for 48 h). BMSC and UCMSC were cultured with allogeneic CD4þ T cells
(responder cells) (at a ratio of 1:5) labelled with violet proliferation dye
in addition to peripheral blood mononuclear cells (PBMC) (used as
stimulator cells) for 5 days. Controls were CD4þ Tcells and PBMCs alone.
After 5 days T cells were analysed via ﬂow cytometry to assess their
proliferative response.
Results: All cells showed positivity for the markers SOX2, Nanog, REX-1,
SSEA-4, Alkaline phosphatase, TRA-1-81, HLA-G and were negative for
OCT 3/4, SSEA-3 and the co-stimulatory markers CD40, CD80, CD86.
BMSC were positive for TRA-1-60, whereas UC MSC were negative.
Differences were seen between BMSC and UC MSC after stimulation
with IFN-g. UC MSC remained negative for the co-stimulatory markers
CD40, 80, 86 and HLA-DR after IFN-g stimulation, but, BMSC showed
up-regulation of HLA-DR after exposure to IFN-g. All cells were negative
for IDO before treatment with IFN-g and became positive after stim-
ulation. T cell proliferation was found to be supressed in all cultures
containing either BMSCs or UC MSCs, showing that cells from both of
these sources have immunomodulatory properties and may be capable
of dampening down immune response in vivo.
Conclusions: Umbilical cord derived MSCs may have more promise
than BMSCs as an allogeneic cell therapy as they do not produce co-
stimulatory markers or MHC (major histocompatibility complex) class II
antigens after culture in vitro in an inﬂammatory environment such as
that which may be found in an osteoarthritic joint.
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THE USE OF A BI-DIRECTIONAL PERFUSION BIOREACTOR FOR
CARTILAGE ENGINEERING PROMOTES THE RECONSTRUCTION OF
HYALINE CARTILAGE
N. Mayer y, L. Silvia z, G. Talo x, A.B. Lovati x, S.A. Riboldi k, M. Moretti z,
F. Mallein-Gerin {. yUniversite Claude Bernard Lyon 1, Lyon, France;
z IRCCS Galeazzi Orthopaedic Inst., Milano, Italy; xGruppo Ospedaliero
San Donato Fndn., Milano, Italy; k SKE Advanced Therapies S.r.l., Milano,
Italy; {CNRS (Ctr. Natl. de la Recherche Scientiﬁque), Lyon, France
Purpose:We previously reported that a cocktail of bonemorphogenetic
protein (BMP)-2, insulin and triiodothyronine (BIT) could trigger
redifferentiation of human chondrocytes after their ampliﬁcation on
plastic, with cartilage-characteristic matrix reconstruction when the
chondrocytes were seeded in collagen sponges (Claus et al., 2011).
However, this matrix was not homogenously distributed in the scaf-
folds, most likely because the collagen sponges were cultivated in static
conditions. With the aim of enhancing cellular access to nutrients and
the soluble factors, bi-directional ﬂow was tested to perfuse the scaf-
folds during cartilage reconstruction.
Methods: After 3 weeks of ampliﬁcation on plastic, HAC were seeded
then cultivated for 21 days in collagen sponges under bi-directional
ﬂow, by using a prototype of OPB (Oscillating Perfusion Bioreactor). We
established a program of perfusion including phases of high and low
perfusion speeds to alternate sequences of cell stimulation and matrix
deposition. For comparison, cultures of HAC in collagen sponges were
performed in static conditions. The status of the chondrocyte pheno-
type and the nature of the matrix synthesized in collagen sponges were
evaluated by real time PCR, Western Blotting and immunohistochem-
istry analyses. The viability and cell proliferation were also monitored.
Results: The results clearly indicate that perfusion improves cartilage
matrix deposition within the sponges, in comparison with static con-
ditions. More precisely, in the sponges cultured in the bioreactor,
redifferentiated and metabolically active HAC produced a cartilaginous
matrix rich in type II and type IX collagens and in glycosaminoglycans,
with no sign of hypertrophy. Interestingly, a much lower amount of type
I collagen was produced in the sponges cultivated in dynamic con-
ditions, indicating therefore that bi-directional perfusion limits the risk
of ﬁbrocartilage formation.Conclusions: The combination of HAC, collagen sponges, and the BIT
cocktail with the bi-directional perfusion bioreactor favors the recon-
struction of hyaline cartilage. Importantly, bi-directional perfusion
abolishes the spatial concentration gradients routinely observed in
scaffolds in static culture. This study also demonstrates the value of a
multi-factorial approach for the design of cell-based grafts for cartilage
repair.
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PLATELET-RICH PLASMA TO STIMULATE CARTILAGE HEALING,
WHICH PRODUCT? A COMPARATIVE IN VITRO STUDY
C. Cavallo y,z, G. Filardo y,x, A. Rofﬁ y,x, E. Kon y,x, M. Marcacci y,x,
G. Desando k,y, F. Sartoni y,z, V. Canella k,y, E. Mariani y,{, A. Facchini y,{,
B. Grigolo y,{. y Istituto Ortopedico Rizzoli, Bologna, Italy; z Lab. RAMSES,
Bologna, Italy; x SC Biomechanics and Technology Innovation Lab.; II
Orthopaedic and Traumatology Clinic, Nano-Biotechnology Lab.,
Bologna, Italy; k Lab. of Immunorheumatology and Tissue Regeneration,
Bologna, Italy; { Lab. of Immunorheumatology and Tissue Regeneration;
Lab. RAMSES, Bologna, Italy
Purpose: Platelet Rich Plasma (PRP), a blood-derived product rich in
growth factors, is a promising treatment for cartilage defects in
Osteoarthritis (OA). Despite its widespread application there is a lack of
in deep studies to demonstrate its real efﬁcacy. Aim of the present study
was to investigate the effects of two different PRP preparations on
chondrocytes from osteoarthritis patients evaluating both the expres-
sion and secretion of pro-inﬂammatory and anabolic markers and the
production of some extracellular matrix proteins.
Methods: Blood from ten human volunteers was used to prepare two
different formulation of PRP: 1) Platelet Rich Plasma with a low con-
centration of platelets and leukocytes (P-PRP), 2) Platelet Rich Plasma
with a high levels of platelets and leukocytes (L-PRP). Before the
experiments, each PRP was evaluated for growth factors and cytokines
content. Chodrocytes were obtained from cartilage tissues of patients
with OA (Kellgren-Lawrence grade I-II-III) undergone surgery and were
isolated by enzymatic procedure. The cells were seeded at a high den-
sity and cultured in presence of three different concentrations (5,10 and
20%) of both P-PRP and L-PRP for 7 days. The in vitro effects of the two
different PRPs on chondrocytes were evaluated through the analysis of
cell proliferation, matrix production and expression of speciﬁc genes.
Results: Our data showed that L-PRP contains higher levels of growth
factors and cytochines compared to P-PRP. Both PRPs at all the concen-
tration evaluated stimulated chondrocyte proliferation throughout the
culture period analyzed; at day 7 P-PRP induced greater cell growth
compared with L-PRP. P-PRP stimulated chondrocyte anabolism as
demonstrated by an increased expression of collagen type II and aggre-
can, while L-PRP promoted catabolic pathways in which different cyto-
kinesare involved.However, L-PRPwasable to induceahigherexpression
of hyaluronic acid synthase-2 and hyaluronan compared to P-PRP.
Conclusions: Our study highlights some effects exerted by two differ-
ent PRP compositions on cultured human chondrocytes. These effects
are reasonably due to the content of platelets, leukocytes, growth fac-
tors and molecules which characterize each compound and that act
synergically to regulate some biological processes. The identiﬁcation of
the optimal amount and ratio of these blood components could ideally
lead to a PRP more suitable for the treatments of cartilage lesions both
of traumatic or degenerative origin.
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THE ENHANCEMENT OF HUMAN BONE MARROW DERIVED
MESENCHYMAL STEM CELLS (HBMSCS) FOR SCAFFOLD-FREE
CARTILAGE-LIKE CELL-SHEETS
M. Itokazu y,z, H. Mera z, Y. Sato x, H. Nakamura y, M. Takagi x,
S. Wakitani z. yDept. of Orthopaedic Surgery, Osaka City Univ. Graduate
Sch. of Med., Osaka, Japan; zGraduate Sch. of Hlth.and Sports Sci.,
Mukogawa Women’s Univ., Nishinomiya, Japan; xDiv. of Biotechnology
and Macromolecular Chemistry, Graduate Sch. of Engineering, Hokkaido
Univ., Sapporo, Japan
Purpose: We are developing the cell therapy, especially using hBMSCs,
for cartilage defect. The result of this therapy would be better if we
could get the cells, having more chondrogenic capacity, enough to tar-
get the cartilage defect. The cell-sheet would be a good candidate of the
applications to get better result. Our colleagues have reported the
